P59594 (SPIKE_SARS) Severe acute respiratory syndrome coronavirus (SARS-CoV)

Spike glycoprotein UniProtKBInterProInteractive Modelling

1255 aa; Sequence (Fasta) ; 26 identical sequences

Available Structures

51 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles Heteromer
Q9BYF1;
NAG;NAG; 11×NAG;NAG;18-1129
Assess
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1) Heteromer
27×NAG;NAG;NAG;NAG; 17×NAG;18-1127
Assess
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2) Heteromer
21×NAG;NAG;NAG;NAG; 16×NAG;18-1127
Assess
Structure of the SARS-CoV spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fr… Heteromer
12×NAG;NAG;NAG; 36×NAG;18-1127
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
Q9BYF1;
18-1119
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
Q9BYF1;
18-1119
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
Q9BYF1;
18-1119
Assess
Structure of a proteolitically resistant core from the severe acute respiratory syndrome coronaviru… Heteromer
GOL;896-1183
Assess
Crystal structure of the SARS-CoV Spike protein fusion core Heteromer
901-1185
Assess
A structure-based mechanism of SARS virus membrane fusion Heteromer
NA;901-1182
Assess
Structure of a Proteolytically Resistant Core from the Severe Acute Respiratory Syndrome Coronaviru… Heteromer
914-1193
Assess
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 Heteromer
P0DTC2; Q9BYF1;
NAG;NAG;ZN;CL;EDO;NAG;321-513
Assess
Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody Heteromer
PO4;NAG;321-512
Assess
Crystal structure of SARS spike protein receptor binding domain in complex with a neutralizing anti… Heteromer
CL;319-509
Assess
Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022 Heteromer
NAG;PO4;NAG;323-513
Assess
Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH… Heteromer
NAG;321-502
Assess
Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody… Heteromer
NAG;321-502
Assess
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor Heteromer
Q9BYF1;
NAG;NAG;ZN;CL;323-502
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human … Heteromer
Q9BYF1;
ZN;CL;323-502
Assess
X-ray crystal structure of the SARS coronavirus spike receptor binding domain in complex with F26G1… Heteromer
Q7TS98; Q8CGS2;
323-502
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
Q9BYF1;
ZN;CL;323-502
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus huma… Heteromer
Q56NL1; Q9BYF1;
NDG;ZN;CL;NAG;324-502
Assess
Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus cive… Heteromer
Q56NL1; Q9BYF1;
NDG;ZN;CL;NAG;324-502
Assess
Crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain co… Heteromer
Q56NL1; Q9BYF1;
ZN;CL;324-502
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
Q56NL1; Q9BYF1;
ZN;CL;324-502
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus cive… Heteromer
Q56NL1; Q9BYF1;
NDG;ZN;CL;NAG;324-502
Assess
Crystal Structure of the Human Coronavirus SARS HR1 motif in complex with pan-CoVs inhibitor EK1 Heteromer
892-968
Assess
A structure-based mechanism of SARS virus membrane fusionhomo-4-merCL;1150-1187
Assess
SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, two S1 CTDs in an upwards conformationhomo-3-merNAG;NAG;NAG;NAG; 12×NAG;18-1120
Assess
SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, one S1 CTD in an upwards conformationhomo-3-merNAG;NAG;NAG; 15×NAG;18-1120
Assess
SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformationhomo-3-merNAG;NAG;NAG; 13×NAG;18-1120
Assess
SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformationhomo-3-mer19×NAG;NAG;NAG;NAG;18-1120
Assess
SARS Spike Glycoprotein, Stabilized variant, C3 symmetryhomo-3-merNAG;NAG; 18×NAG;18-1120
Assess
SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, C3 symmetryhomo-3-merNAG;NAG;NAG; 15×NAG;18-1120
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conforma…homo-3-mer18-1119
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conforma…homo-3-mer18-1119
Assess
Structure of SARS-CoV spike glycoproteinhomo-3-mer33-1120
Assess
Prefusion structure of SARS-CoV spike glycoprotein, conformation 2homo-3-mer18-1104
Assess
Prefusion structure of SARS-CoV spike glycoprotein, conformation 1homo-3-mer42×NAG;18-1104
Assess
SARS-CoV spike glycoproteinhomo-3-mer261-1058
Assess
Post-fusion structure of SARS-CoV spike glycoproteinhomo-3-mer24×NAG;688-1178
Assess
Post-fusion hairpin conformation of the sars coronavirus spike glycoproteinhomo-3-merCL;890-981
Assess
Solution Structure of the SARS-Coronavirus HR2 Domainhomo-3-mer1141-1193
Assess
A structure-based mechanism of SARS virus membrane fusionhomo-3-mer940-973
Assess
A structure-based mechanism of SARS virus membrane fusionhomo-2-mer926-1181
Assess
Crystal structure of SARS spike protein receptor binding domainhomo-2-mer320-502
Assess
Structure of the N-terminal domain (NTD)of SARS-CoV spike proteinmonomerNAG;NAG;18-289
Assess
NMR Structure and Localization of a Large Fragment of the SARS-CoV Fusion Protein: Implications in …monomer758-821
Assess
Solution structure of Fusion peptidemonomer770-788
Assess
Solution Structure of Pre Transmembrane domainmonomer1185-1202
Assess
Solution Structure of Internal Fusion Peptidemonomer873-888
Assess

3 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
homo-3-mer0.727cn8.1.A15-1126
76.97
Assess
homo-3-mer0.706zgf.1.A14-1126
76.14
Assess
homo-3-mer0.676acd.1.A18-1119
100.00
Assess

Alignments